Home
Medicines
Companies
COVID-19
Direct Healthcare Professional Communications
Active Ingredients
Advanced Search
Adverse Event Reporting
Login
Search Medicine Database
Home
Medicines
Companies
COVID-19
More
expand_more
Login
menu
Home
Active Ingredients
Abatacept
Abatacept
Medicine
Status
PIL
SPC
XPIL
Legal Category
Active Ingredient(s)
Company
ORENCIA 125 mg solution for injection in pre-filled pen
No Recent Update
PIL
03/03/22
SPC
03/03/22
Yes
A
Abatacept
Bristol-Myers Squibb Pharma EEIG
ORENCIA 250 mg powder for concentrate for solution for infusion
No Recent Update
PIL
03/03/22
SPC
03/03/22
Yes
A
Abatacept
Bristol-Myers Squibb Pharma EEIG
ORENCIA 50 mg, 87.5 mg and 125 mg solution for injection (pre-filled syringe)
No Recent Update
PIL
03/03/22
SPC
03/03/22
Yes
A
Abatacept
Bristol-Myers Squibb Pharma EEIG
This medicine and its document have not been updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)
